SAB Biotherapeutics
SABS
SABS
39 hedge funds and large institutions have $1.71M invested in SAB Biotherapeutics in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 6 closing their positions.
Holders
39
Holders Change
+1
Holders Change %
+2.63%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
7
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
